Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

$ 13.50

4.9
(353)
In stock
Description

PDF] Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment.

Pharmaceuticals, Free Full-Text

Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses

Frontiers Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report

Frontiers Current Triple-Negative Breast Cancer Subtypes

Novel Therapies for Metastatic Triple-Negative Breast Cancer

Cancers, Free Full-Text

Diagnostics, Free Full-Text

Long Non-Coding RNAs in Triple-Negative Breast Cancer

Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer - ScienceDirect